We are live on
!
Find out more
PM
Prosight Management Portfolio holdings
AUM
$610M
1-Year Est. Return
40.86%
This Fund
S&P 500
This Quarter
Est. Return
-9.07%
1 Year Est. Return
+40.86%
3 Year Est. Return
+46.17%
5 Year Est. Return
+1.2%
10 Year Est. Return
–
AUM
$142M
AUM Growth
-$8.14M
(-5.4%)
Cap. Flow
+$10.8M
Cap. Flow
% of AUM
7.59%
Top 10 Holdings %
Top 10 Hldgs %
73.63%
Holding
41
New
6
Increased
12
Reduced
12
Closed
8
Top Buys
| 1 |
MeiraGTx Holdings
MGTX
|
+$5.86M |
| 2 |
Charles River Laboratories
CRL
|
+$4.94M |
| 3 |
Cue Biopharma
CUE
|
+$4.82M |
| 4 |
Prothena Corp
PRTA
|
+$4.53M |
| 5 |
Shattuck Labs
STTK
|
+$3.05M |
Top Sells
| 1 |
ZGNX
Zogenix, Inc.
ZGNX
|
+$5.9M |
| 2 |
Encompass Health
EHC
|
+$5.4M |
| 3 |
Oscar Health
OSCR
|
+$5.12M |
| 4 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
+$4.18M |
| 5 |
MORF
Morphic Holding, Inc. Common Stock
MORF
|
+$3.45M |
Sector Composition
| 1 | Healthcare | 98.46% |
| 2 | Industrials | 1.54% |
| 3 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LKFT
1
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.94B
| $23.2M | 16.33% |
374,000
+28,100
| +8% | +$1.72M |
|
|
2
Prothena Corp
PRTA
$447M
| $20.7M | 14.58% |
566,538
+125,538
| +28% | +$4.53M |
|
|
ALBO
3
DELISTED
Albireo Pharma Inc
ALBO
| $14.3M | 10.08% |
480,000
-34,082
| -7% | -$998K |
|
|
4
Charles River Laboratories
CRL
$11.1B
| $8.95M | 6.3% |
31,500
+16,019
| +103% | +$4.94M |
|
|
KALV
5
DELISTED
KalVista Pharmaceuticals
KALV
| $8.69M | 6.11% |
589,270
+179,650
| +44% | +$2.58M |
|
|
6
Cue Biopharma
CUE
$127M
| $7.37M | 5.19% |
50,343
+22,708
| +82% | +$4.82M |
|
7
Aldeyra Therapeutics
ALDX
$116M
| $6.22M | 4.38% |
1,400,239
+244,939
| +21% | +$976K |
|
|
8
MeiraGTx Holdings
MGTX
$1.17B
| $5.27M | 3.71% |
+380,700
| New | +$5.86M |
|
|
KZR
9
DELISTED
Kezar Life Sciences
KZR
| $4.99M | 3.51% |
30,000
-6,000
| -17% | -$861K |
|
|
CNVY
10
DELISTED
Convey Health Solutions Holdings, Inc.
CNVY
| $4.89M | 3.44% |
748,134
-28,866
| -4% | -$191K |
|
11
Alnylam Pharmaceuticals
ALNY
$37.4B
| $3.71M | 2.61% |
22,704
-9,203
| -29% | -$1.4M |
|
12
Agilon Health
AGL
$2.07B
| $3.55M | 2.5% |
5,600
-400
| -7% | -$206K |
|
|
13
Shattuck Labs
STTK
$609M
| $3.4M | 2.4% |
798,718
+538,475
| +207% | +$3.05M |
|
14
Rocket Pharmaceuticals
RCKT
$401M
| $3.22M | 2.27% |
203,268
+74,563
| +58% | +$1.29M |
|
15
QuidelOrtho
QDEL
$1.24B
| $2.89M | 2.03% |
+25,675
| New | +$2.74M |
|
|
16
Encompass Health
EHC
$10.9B
| $2.84M | 2% |
50,154
-103,435
| -67% | -$5.4M |
|
|
17
Oscar Health
OSCR
$9.29B
| $2.37M | 1.67% |
237,500
-687,500
| -74% | -$5.12M |
|
|
ACCD
18
DELISTED
Accolade Inc
ACCD
| $2.18M | 1.54% |
124,393
+74,393
| +149% | +$1.37M |
|
|
SEM
19
DELISTED
Select Medical
SEM
| $2.18M | 1.53% |
+168,503
| New | +$2.22M |
|
20
CRISPR Therapeutics
CRSP
$5.02B
| $2.13M | 1.5% |
34,000
+16,636
| +96% | +$1.04M |
|
21
InMode
INMD
$880M
| $1.85M | 1.3% |
+50,000
| New | +$2.24M |
|
22
Mirum Pharmaceuticals
MIRM
$7.37B
| $1.63M | 1.15% |
+73,930
| New | +$1.51M |
|
23
Globus Medical
GMED
$10.6B
| $1.33M | 0.93% |
18,000
-2,188
| -11% | -$152K |
|
24
ARS Pharmaceuticals
SPRY
$743M
| $1.14M | 0.8% |
325,365
+271,550
| +505% | +$1.18M |
|
25
NeoGenomics
NEO
$1.87B
| $772K | 0.54% |
+63,524
| New | +$1.34M |
|
Similar funds
PL
BFC
ACM
FFWA
SAM
CBB
AIG
IA